Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03599557 · ClinicalTrials.gov registry record · NA
The STOP-HPV Trial 1: Communication Intervention
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 48
- Enrollment target
NCT03599557 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 48 participants.
The verdict
NCT03599557, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
Study Summary
Most adolescents who receive human papillomavirus (HPV) vaccine are vaccinated in pediatric practices, yet missed opportunities (MOs) for HPV vaccination occur often and lead to low HPV vaccination rates. This cluster randomized clinical trial (RCT) will test the effectiveness (and cost-effectiveness) of training providers on HPV vaccine communication to reduce MOs and increase HPV vaccination rates.
Interventions
- BEHAVIORAL STOP-HPV communication intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2018-08-07 |
| Est. Completion | 2019-10-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03599557
The ClinicalTrials.gov registry entry for NCT03599557 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which STOP-HPV communication intervention is the first listed.
NCT03599557 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03599557 about?
NCT03599557 is a clinical study titled "The STOP-HPV Trial 1: Communication Intervention". Most adolescents who receive human papillomavirus (HPV) vaccine are vaccinated in pediatric practices, yet missed opportunities (MOs) for HPV vaccination occur often and lead to low HPV vaccination rates. This cluster randomized clinical trial (RCT) will test the effectiveness (and cost-effectivenes...
What is the current status of trial NCT03599557?
This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2018-08-07. Estimated completion is 2019-10-21.
What interventions are being tested in trial NCT03599557?
The interventions under investigation include: STOP-HPV communication intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03599557?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.